CGEM Q1 2021 Earnings — Cullinan Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

CGEMCullinan Therapeutics, Inc.

$894M

Q1 2021 Earnings

Healthcare Medical - Pharmaceuticals

Income Statement

Revenue

$19M

Gross Profit

$19M100.0% margin

Operating Income

$1M7.2% margin

Net Income

-$70,000-0.4% margin

EPS (Diluted)

$-0.00

QoQ Revenue Growth

+Infinity%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$2M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$480M

Total Liabilities

$10M

Stockholders' Equity

$467M

Cash & Equivalents

$294M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$19M	$0	—
Gross Profit	$19M	$0	—
Operating Income	$1M	-$6M	+124.8%
Net Income	-$70,000	-$5M	+98.6%